Companies / China
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Alliance Boots Enters Market
January 2007 | FDI AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
UK-based pharmacy chain and wholesaler Alliance Boots has formed a joint venture with China's third largest wholesaler, Guangzhou Pharmaceuticals, to penetrate one of the world's largest and fastest growing pharmaceutical markets. BMI strongly endorses Alliance Boots' strategy and expects the new entity to swiftly establish itself and simultaneously present opportunities to drugmakers that have existing relationships with the UK firm. On the back of robust financial growth, BMI expects China's pharmaceutical market to reach a value of nearly US$47bn by 2010, up a phenomenal 73% from our current valuation of approximately US$27bn.